APA (7th ed.) Citation

Biondo, A., Beesley, S., Burcombe, R., Cominos, M., Sevitt, T., Taylor, H., & Shah, R. (2012). 14 Audit of the management of epithelial growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) patients within the Kent Oncology Centre and its associated units. Lung Cancer (01695002), 75, S5. https://doi.org/10.1016/S0169-5002(12)70015-6

Chicago Style (17th ed.) Citation

Biondo, A., S. Beesley, R. Burcombe, M. Cominos, T. Sevitt, H. Taylor, and R. Shah. "14 Audit of the Management of Epithelial Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) Patients Within the Kent Oncology Centre and Its Associated Units." Lung Cancer (01695002) 75 (2012): S5. https://doi.org/10.1016/S0169-5002(12)70015-6.

MLA (9th ed.) Citation

Biondo, A., et al. "14 Audit of the Management of Epithelial Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) Patients Within the Kent Oncology Centre and Its Associated Units." Lung Cancer (01695002), vol. 75, 2012, p. S5, https://doi.org/10.1016/S0169-5002(12)70015-6.